Market Movers (8-K)
See all →NYSE
Ellington Financial Inc. announced the successful closing of a $150 million offering of 7.375% senior unsecured notes due 2030, aimed at general corporate purposes and asset acquisition.
Capital raise
NYSE
Ellington Financial Inc. announced plans to offer $100 million in 7.375% senior unsecured notes due 2030 to fund general corporate purposes and asset purchases.
Capital raise
NYSE
Ellington Financial Inc. announced its Board of Directors has declared monthly and quarterly dividends for its common and preferred stockholders, with payment dates in late October and September 2026.
NYSE
Ellington Financial Inc. announced an estimated book value per common share of $13.63 as of July 31, 2026, including a declared monthly dividend.
NYSE
Ellington Financial Inc. announced an estimated book value per common share of $13.61 as of June 30, 2026.
NYSE
Ellington Financial Inc. announced a monthly common stock dividend of $0.13 per share, payable August 31, 2026.
Quarterly Earnings (10-Q)
See all →NYSE
Ellington Financial Inc. announced its Q2 2026 financial results, showcasing a significant increase in net income and growth across its key business segments.
Capital raise
NYSE
Ellington Financial Inc. announced a significant increase in net income and EPS for the third quarter of 2025, driven by robust performance in its investment and Longbridge segments.
Capital raise
Better than expected
NYSE
Ellington Financial Inc. reported a decrease in GAAP net income for Q2 2025 but saw an increase in Adjusted Distributable Earnings and improved debt-to-equity ratios, driven by strong performance in its Longbridge segment and strategic portfolio adjustments.
Better than expected
Capital raise
NYSE
Ellington Financial Inc. reports its financial results for the first quarter of 2025, showcasing strategic asset management amidst market fluctuations.
NYSE
Ellington Financial Inc. reports a net income attributable to common stockholders of $16.2 million for the third quarter of 2024, compared to $6.6 million for the same period in 2023.
Better than expected
Capital raise
NYSE
Ellington Financial Inc. reports a complex second quarter with increased net income but also significant fluctuations in asset values and interest rate impacts.
Better than expected
Annual Reports (10-K)
NYSE
Ellington Financial Inc. achieved significant portfolio growth and strong financial performance in 2025, driven by strategic investments and robust segment results.
Capital raise
Better than expected
NYSE
Ellington Financial Inc. reports its 2024 financial results, highlighting a strategic portfolio shift and increased capital base following the Arlington Asset Investment Corp. merger.
NYSE
Ellington Financial Inc.'s 10-K filing details the company's registered securities, including common stock and several series of preferred stock, all listed on the NYSE.
Insider Trading (Form 4)
See all →NYSE
Ronald I Simon, a Director of Ellington Financial Inc., received 10,181 shares of common stock on September 9, 2026.
NYSE
Edward Resendez, a Director of Ellington Financial Inc., received 10,181 shares of common stock on September 9, 2026.
NYSE
Stephen J Dannhauser, a Director of Ellington Financial Inc., received 10,181 shares of common stock on September 9, 2026.
NYSE
Lisa Mumford, a Director of Ellington Financial Inc., received 10,181 shares of common stock on September 9, 2026.
NYSE
Michael W Vranos, Co-Chief Investment Officer of Ellington Financial Inc., reported a transaction in 6,794 shares of common stock on August 5, 2026.
NYSE
Co-Chief Investment Officer Michael W. Vranos reported the acquisition of 161,934 shares of Ellington Financial Inc. common stock as part of a quarterly incentive fee payment.
Proxy Statements (Def-14A)
NYSE
Ellington Financial Inc. has filed a definitive proxy statement with the SEC, indicating upcoming shareholder meetings and voting on key company matters.
NYSE
Ellington Financial Inc. will hold its 2025 Annual Meeting of Stockholders virtually on May 29, 2025, to vote on director elections, executive compensation, and the ratification of the independent auditor.
NYSE
Ellington Financial Inc. has filed a definitive proxy statement with the SEC, signaling upcoming shareholder actions.
NYSE
Ellington Financial Inc. is holding its annual meeting on May 17, 2024, to vote on director elections, executive compensation, auditor ratification, and an amendment to increase authorized common shares.
Capital raise
Schedule 13G - Passive Investments
NYSE
Vanguard Capital Management has reported beneficial ownership of 5% of Ellington Financial Inc.'s common stock as of June 30, 2026.
NYSE
The Vanguard Group reported 0% beneficial ownership in Ellington Financial Inc. following an internal realignment for disaggregated reporting.
NYSE
SCHEDULE 13G/A: BlackRock Boosts Stake in Ellington Financial to 15.3%
BlackRock, Inc. has reported an increased beneficial ownership of 15.3% in Ellington Financial Inc.'s common stock as of December 31, 2025.